{
    "Trade/Device Name(s)": [
        "ADVIA Centaur Testosterone (TSTO)",
        "ADVIA Centaur\u00ae Testosterone (TSTO)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K133491",
    "Predicate Device Reference 510(k) Number(s)": [
        "K934562"
    ],
    "Regulatory Class": "Class I (Reserved)",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "February 21, 2014",
    "Summary Letter Received Date": "January 7, 2014",
    "Submission Date": "December 18, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1680"
    ],
    "Regulation Name(s)": [
        "Testosterone test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Testosterone (total)",
        "Testosterone (bound and unbound)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur",
        "ADVIA Centaur XP"
    ],
    "Method(s)/Technology(ies)": [
        "Competitive immunoassay",
        "Chemiluminescent technology"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Testosterone (TSTO) assay with modification to polyclonal antibody pool for in vitro quantitative measurement of testosterone in serum.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of total testosterone (bound and unbound) in serum using the ADVIA Centaur and ADVIA Centaur XP systems to aid in the diagnosis and treatment of disorders involving androgens.",
    "fda_folder": "Clinical Chemistry"
}